Rays of Belief invests approx USD 2M in US subsidiary via right issue

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights
  • Rays of Belief invests approx USD 2 million in US subsidiary via right issue
  • Transaction completed on September 17, 2026 at par value of USD 1 per share
  • Mom's Belief US Inc reported turnover of USD 38.25 lakh as on March 31, 2026
  • Investment aims to expand specialized healthcare services in the US market
powered bylight_fuzz_icon
51192604

*this image is generated using AI for illustrative purposes only.

Rays of Belief invested approximately USD 2 million in its wholly owned subsidiary, Mom's Belief US Inc, through a right issue completed on September 17, 2026. The cash injection supports the company's expansion into specialized healthcare services in the United States.

The investment aligns with the objects of the initial public offer filed on September 8, 2026. The transaction was executed at par value of USD 1 per share.

Transaction Details

The board approved the further investment to leverage existing capabilities and infrastructure in the target entity. The deal is classified as a related party transaction conducted at arm's length. No promoter or promoter group holds interest in the subsidiary beyond the shares held by Rays of Belief.

Detail Information
Target Entity Mom's Belief US Inc
Investment Amount Approx USD 2,000,000
Mode Right Issue (Cash)
Share Price USD 1 per share
Date of Completion September 17, 2026
Regulatory Compliance FEMA 1999 compliances only

Subsidiary Profile

Mom's Belief US Inc, incorporated on April 4, 2025, operates in the healthcare industry. It specializes in allergy and immunology, focusing on the diagnosis and management of immune system disorders.

As on March 31, 2026, the subsidiary reported:

  • Turnover: USD 38,25,615
  • Paid-up Capital: USD 100

Rays of Belief continues to hold 100% of the share capital following this investment. No change in the shareholding structure occurred.

Historical Stock Returns for Rays of Belief

1 Day5 Days1 Month6 Months1 Year5 Years
-4.23%-0.32%-6.69%-6.69%-6.69%-6.69%

How will the USD 2 million capital injection accelerate Mom's Belief US Inc's patient acquisition strategy in the competitive US allergy and immunology market?

What specific regulatory milestones or clinical partnerships is Rays of Belief targeting to scale its specialized healthcare services in the United States?

Given the subsidiary's low paid-up capital prior to this investment, what operational infrastructure upgrades are planned with the new funds to support revenue growth beyond the current turnover of ~USD 3.8 million?

LRSD Capital acquires 6.48% stake in Rays of Belief via IPO allotment

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • LRSD Capital Pvt Ltd acquired 13,54,233 shares in Rays of Belief Limited
  • The stake represents 6.48% of the total diluted share capital
  • Acquisition was made via IPO allotment on September 4, 2026
  • RGSL Investment LVF 1 and Ritu Dua are Persons Acting in Concert
  • Rays of Belief Limited is set to list on NSE and BSE on September 8, 2026
powered bylight_fuzz_icon
50483157

*this image is generated using AI for illustrative purposes only.

LRSD Capital Pvt Ltd acquired a 6.48% stake in Rays of Belief Limited through an initial public offering allotment. The transaction involved the purchase of 13,54,233 equity shares on September 4, 2026.

The acquisition was made in concert with RGSL Investment LVF 1 and Ritu Dua. LRSD Capital is not part of the promoter group of Rays of Belief Limited. The shares were allotted as part of the IPO process, with the company scheduled to list on the NSE and BSE on September 8, 2026.

Acquisition Details

The filing under Regulation 29(1) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, discloses the following shareholding structure:

Metric Value
Shares acquired 13,54,233
Stake percentage 6.48%
Mode of acquisition IPO Allotment
Date of allotment September 4, 2026
Listing date September 8, 2026

Before this acquisition, LRSD Capital and its Persons Acting in Concert held no shares or voting rights in Rays of Belief Limited. Following the allotment, their total holding stands at 13,54,233 shares, representing 6.48% of the total diluted share capital.

What the Numbers Show

The total equity share capital of Rays of Belief Limited remains at 2,09,01,682 equity shares of ₹10 each after the acquisition. This indicates that the shares acquired by LRSD Capital were likely part of the fresh issue component of the IPO rather than an open market transfer from existing shareholders, as the total voting capital figure did not change between the pre-acquisition and post-acquisition disclosures in the filing.

RGSL Investment LVF 1 is included as a Person Acting in Concert by way of abundant caution. Its corpus is predominantly contributed by Rajasthan Global Securities Private Limited and LRSD Capital Private Limited. Investment decisions for the scheme are exercised by its Investment Manager in accordance with applicable fund documents.

Historical Stock Returns for Rays of Belief

1 Day5 Days1 Month6 Months1 Year5 Years
-4.23%-0.32%-6.69%-6.69%-6.69%-6.69%

How might LRSD Capital's 6.48% stake influence the initial price discovery and volatility of Rays of Belief Limited upon its listing on September 8, 2026?

What is the strategic rationale behind LRSD Capital acquiring this stake in concert with RGSL Investment LVF 1, and does it signal a long-term investment thesis or a short-term arbitrage opportunity?

Given that the total equity share capital remained unchanged, what does the reliance on fresh issue funds imply about Rays of Belief Limited's current capital requirements and growth plans?

1 Year Returns:-6.69%